Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Nneka Ufere

Liver Transplant · MGH

View

Dr. Vinay Jahagirdar

Liver Transplant · Medical College of Virginia

View

Dr. Lauren Feld

Liver Transplant · UMass Memorial

View

Dr. Sonali Paul

Liver Transplant · UCMC

View

Dr. Pierre Gholam

Liver Transplant · CWRU

View

Dr. Elliot Tapper

Liver Transplant · UM

View

Dr. Saurabh Sethi

General GI · Oja Health

View

Dr. Sara Horst

IBD · Vanderbilt

View

Dr. Wendi LeBrett

General GI · ModernGut

View

Dr. Treta Purohit

General GI · Oshi Health

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    ABDr. Alan Bonder

    Dr. Alan Bonder

    Gastroenterology · Hepatology & Liver Transplantation
    Beth Israel Deaconess Medical Center
    alan

    Research

    Metabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinoma

    2025

    Via European Journal of Gastroenterology & Hepatology

    Research

    Burden of illness for patients with primary biliary cholangitis: an observational study of clinical characteristics and healthcare resource utilization

    2025

    Via Journal of Comparative Effectiveness Research

    Research

    Azathioprine or Mycophenolate Mofetil: Which Should Be Used in Patients With Autoimmune Hepatitis?

    2025

    Via Gastroenterology & Hepatology

    Research

    Performance of the Mayo Risk Score in Predicting Transplant and Mortality in a Single-Center U.S. Cohort of Primary Sclerosing Cholangitis

    2025

    Via Journal of Clinical Medicine

    Apr 14, 2025Journal Article

    A nationwide study of primary biliary cholangitis prevalence, geographic distribution, and health care providers.

    ​

    Written by 1 Roon author & 9 others

    Via Hepatology Communications

    Research

    Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival

    2025

    Via JHEP Reports

    Research

    Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial

    2025

    Via Journal of Hepatology

    Research

    Primary biliary cholangitis has the worst quality of life indicators among the autoimmune liver diseases: A United States cohort

    2025

    Via Annals of Hepatology

    Research

    Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis

    2025

    Via Journal of Hepatology

    Research

    Evolving trends and comparative outcomes of bridging transarterial locoregional therapy in liver transplant candidates with hepatocellular carcinoma

    2025

    Via Liver Transplantation

    Research

    Hepatocellular Carcinoma Recurrence After Liver Transplantation: Current Insights and Future Directions

    2025

    Via Journal of Clinical Medicine

    Research

    Outcomes of Living-Donor Liver Transplantation for Cholangiocarcinoma Versus Hepatocellular Carcinoma in the United States

    2025

    Via Journal of Clinical Medicine

    Research

    Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Fatigue and Pruritus in Primary Sclerosing Cholangitis: A U.S. Single-Center Study

    2025

    Via Journal of Clinical Medicine

    Research

    Epidemiology and health care burden of autoimmune liver diseases in Mexico

    2024

    Via Clinical Liver Disease

    Research

    Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

    2024

    Via Hepatology